 |
 |
In a message dated 12/2/98 12:14:06 AM Eastern Standard Time, [log in to unmask] writes: << According to fairly reliable sources, entacapone will be marketed in Europe as COMTESS and in the US as COMTAN. There is only slight chance that FDA approval could come before the middle of next summer. There are n reports of liver damage from entacapone. I have been taking entacapone for several years and, to the best of my knowledge, suffered no ill effects. >> May I ask, if it is not approved in the US, how you have been taking for years? Gerry